Dehydrocorydaline attenuates bone cancer pain by shifting microglial M1/M2 polarization toward the M2 phenotype.
about
Dehydrocorydaline attenuates bone cancer pain by shifting microglial M1/M2 polarization toward the M2 phenotype.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Dehydrocorydaline attenuates b ...... ation toward the M2 phenotype.
@en
Dehydrocorydaline attenuates b ...... ation toward the M2 phenotype.
@nl
type
label
Dehydrocorydaline attenuates b ...... ation toward the M2 phenotype.
@en
Dehydrocorydaline attenuates b ...... ation toward the M2 phenotype.
@nl
prefLabel
Dehydrocorydaline attenuates b ...... ation toward the M2 phenotype.
@en
Dehydrocorydaline attenuates b ...... ation toward the M2 phenotype.
@nl
P2093
P2860
P356
P1433
P1476
Dehydrocorydaline attenuates b ...... ation toward the M2 phenotype.
@en
P2093
Chenchen Wang
Wenwen Huo
Xiaoping Gu
Yanting Mao
Ying Zhang
Yishan Lei
Yulin Huang
P2860
P304
1744806918781733
P356
10.1177/1744806918781733
P577
2018-01-01T00:00:00Z